Clinical decision tool for predicting treatment week eight response and sustained virologic response in patients treated with boceprevir (BOC) plus peginterferon alfa and ribavirin (PR)

Conference Proceedings

S Devine, MW Kattan, AJ Muir, L Pedicone, F Poordad, T Poynard, MS Sulkowski, AJ Thompson

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | WILEY-BLACKWELL | Published : 2013